1. Home
  2. SER vs FSEA Comparison

SER vs FSEA Comparison

Compare SER & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • FSEA
  • Stock Information
  • Founded
  • SER 2017
  • FSEA 1890
  • Country
  • SER United States
  • FSEA United States
  • Employees
  • SER N/A
  • FSEA N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • FSEA Savings Institutions
  • Sector
  • SER Health Care
  • FSEA Finance
  • Exchange
  • SER Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • SER 53.5M
  • FSEA 51.2M
  • IPO Year
  • SER 2018
  • FSEA N/A
  • Fundamental
  • Price
  • SER $5.80
  • FSEA $11.11
  • Analyst Decision
  • SER Strong Buy
  • FSEA
  • Analyst Count
  • SER 1
  • FSEA 0
  • Target Price
  • SER $11.00
  • FSEA N/A
  • AVG Volume (30 Days)
  • SER 12.2K
  • FSEA 7.4K
  • Earning Date
  • SER 05-24-2025
  • FSEA 05-20-2025
  • Dividend Yield
  • SER N/A
  • FSEA N/A
  • EPS Growth
  • SER N/A
  • FSEA N/A
  • EPS
  • SER N/A
  • FSEA N/A
  • Revenue
  • SER $56,000.00
  • FSEA $15,874,000.00
  • Revenue This Year
  • SER N/A
  • FSEA N/A
  • Revenue Next Year
  • SER N/A
  • FSEA N/A
  • P/E Ratio
  • SER N/A
  • FSEA N/A
  • Revenue Growth
  • SER N/A
  • FSEA 70.41
  • 52 Week Low
  • SER $3.81
  • FSEA $8.60
  • 52 Week High
  • SER $14.57
  • FSEA $11.69
  • Technical
  • Relative Strength Index (RSI)
  • SER 55.22
  • FSEA 51.71
  • Support Level
  • SER $5.12
  • FSEA $10.80
  • Resistance Level
  • SER $6.61
  • FSEA $11.24
  • Average True Range (ATR)
  • SER 0.49
  • FSEA 0.12
  • MACD
  • SER -0.01
  • FSEA 0.01
  • Stochastic Oscillator
  • SER 56.45
  • FSEA 65.96

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

Share on Social Networks: